908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced outcomes of its joint innovation partnership with Transcenta, a global biotherapeutics company. Transcenta has implemented 908 Devices’ technologies within its Process and Product Development Center and Manufacturing Facility in Hangzhou, China to facilitate their biopharma analytical workflows [...]

AMSTERDAM -- LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi® Cell Avidity Analyzer at INmune Bio (NASDAQ: INMB). INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer [...]

New 20/15 Visioneers and Eagle Genomics Partnership to Promote Global Microbiome Education and Standardization New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights. Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has [...]

RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today published its first sustainability report. The report highlights key actions taken in 2020, as well as initiatives underway to accelerate future sustainability goals that advance the Company's [...]

BOSTON and LAUSANNE, Switzerland -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions [...]

MARS® Systems and MARS® MAG Line purifies target cells in a rapid, automated, flexible process with a cost-effective solution. SANTA CLARA, CA, USA -- Applied Cells, a provider of cell preparation and isolation solutions for tumor and immune biology research, today announced the release of its MARS® MAG Line. Developed to support the expansion of turnkey applications [...]

New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and   Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights.  Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a leading computational and scientific informatics management consulting and marketing company, and Eagle Genomics Ltd. (Eagle), a leading global microbiome data and analytics company, announced a new partnership, focused on raising awareness of improved microbiome [...]

Alliance to expand the range of therapeutic and vaccine applications for the BioXp™ system SAN DIEGO -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Codex DNA will integrate [...]

Cambridge, UK – 21 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce that OncoArendi Therapeutics SA (WSE: OAT), a biotechnology company which specializes in the discovery and development of new drugs, has licensed Flare™ for use in its internal development programs. Cresset software uses its proprietary descriptors of [...]